Join to View Full Profile
5841 S Maryland Ave# MC2115Chicago, IL 60637
Phone+1 773-834-1076
Dr. Churpek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jane Churpek is a hematologist oncologist and cancer geneticist in Madison, WI. She received her medical degree from Medical College of Wisconsin and trained at The University of Chicago. She has been in practice 12 years. She specializes in the diagnosis, including genetic testing, and management of individuals with bone marrow failure, myelodysplastic syndrome or low blood counts, especially when these run in the family. She also provides comprehensive diagnosis, early detection and prevention for individuals with hereditary cancer syndromes such as li-fraumeni syndrome, inherited bone marrow failure syndromes, hereditary breast and ovarian cancer syndrome, familial leukemia syndromes, BAP1 syndrome, and more.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2008 - 2011- University of ChicagoResidency, Internal Medicine, 2005 - 2008
Medical College of WisconsinClass of 2005
Certifications & Licensure
IL State Medical License 2008 - 2026
WI State Medical License 2019 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders.Christopher M Sande, Stone Chen, Dana V Mitchell, Ping Lin, Diana M Abraham
The Journal of Clinical Investigation. 2025-04-03 - 1 citationsReducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement.Uma Borate, Kelly Pugh, Allyson Waller, Rina Li Welkie, Ying Huang
Blood. 2025-03-27 - 2 citationsTreatment of Pleural Mesothelioma: ASCO Guideline Update.Hedy L Kindler, Nofisat Ismaila, Lyudmila Bazhenova, Quincy Chu, Jane E Churpek
Journal of Clinical Oncology. 2025-03-10
Press Mentions
Researchers Find Indicators for Breast Cancer Survivors Chance of LeukemiaDecember 8th, 2015
Researchers Focus on Risk Factors for Leukemia After Breast Cancer TreatmentDecember 7th, 2015
Characteristics That May Increase a Breast Cancer Survivor's Risk of Developing Leukemia Following Treatment IdentifiedDecember 7th, 2015- Join now to see all
Grant Support
- Mechanisms of Parp inhibitor-induced bone marrow toxicitiesUNIVERSITY OF WISCONSIN-MADISON2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
